![Precision medicine for metastatic breast cancer—limitations and solutions | Nature Reviews Clinical Oncology Precision medicine for metastatic breast cancer—limitations and solutions | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrclinonc.2015.123/MediaObjects/41571_2015_Article_BFnrclinonc2015123_Fig1_HTML.jpg)
Precision medicine for metastatic breast cancer—limitations and solutions | Nature Reviews Clinical Oncology
![Nature Reviews Disease Primers on X: "Management of early #breastcancer is based on #tumour burden and subtype - learn more in our Primer https://t.co/3LDzqltJIu #ESMO19 https://t.co/OpB8MBtn12" / X Nature Reviews Disease Primers on X: "Management of early #breastcancer is based on #tumour burden and subtype - learn more in our Primer https://t.co/3LDzqltJIu #ESMO19 https://t.co/OpB8MBtn12" / X](https://pbs.twimg.com/media/EFYPrPrWkAA8Z6M.jpg:large)
Nature Reviews Disease Primers on X: "Management of early #breastcancer is based on #tumour burden and subtype - learn more in our Primer https://t.co/3LDzqltJIu #ESMO19 https://t.co/OpB8MBtn12" / X
![LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis | Nature Communications LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fncomms15059/MediaObjects/41467_2017_Article_BFncomms15059_Fig1_HTML.jpg)
LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis | Nature Communications
![Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease | Nature Reviews Clinical Oncology Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease | Nature Reviews Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrclinonc.2016.66/MediaObjects/41571_2016_Article_BFnrclinonc201666_Fig1_HTML.jpg)